NCT04111692 A Prospective Observational Study of Foam Sclerotherapy .
| NCT ID | NCT04111692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Autosomal Dominant Polycystic Kidney |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2017-11-06 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2017-11-06 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Clinical diagnosis of ADPKD or ADPLD * 1-3 large, non-exophytic liver or kidney cyst * Compressive symptoms from dominant cyst Exclusion Criteria: * Age \<18 years * Absence of ADPKD or ADPLD * Largest cyst \<4cm in all 3 dimensions or largest cyst volume \<400cc * \>3 large, non-exophytic liver or kidney cyst(s) ≥4cm in all 3 dimensions (cyst volume ≥400cc) * Unwilling to comply with study follow-up protocol to 12 ± 1months post-FS * Lacking capacity to provide informed consent to FS of liver or kidney cysts * Pregnancy
Contact & Investigator
Marie Hogan, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT04111692 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Autosomal Dominant Polycystic Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04111692 currently recruiting?
Yes, NCT04111692 is actively recruiting participants. Contact the research team at howe.cassie@mayo.edu for enrollment information.
Where is the NCT04111692 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT04111692 clinical trial?
NCT04111692 is sponsored by Mayo Clinic. The principal investigator is Marie Hogan, MD, PhD at Mayo Clinic. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.